Recent studies of CRC have found that overexpression of SOX9 in vitro and in vivo was related to several pro-oncogenic properties, including the ability to promote proliferation, inhibit senescence, and collaborate with other oncogenes in neoplastic transformation [6, 49, 50, 73, 160]. The gene discussed is SOX9; the disease is colorectal carcinoma.